Dr. Ahmed Al-Ogaili, MD

Dr. Al-Ogaili practices at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Al-Ogaili's NPI, 1356719025, was assigned on September 10, 2015. Dr. Al-Ogaili holds Pennsylvania license MD484198.

Dr. Al-Ogaili's primary practice is Penn Presbyterian Medical Center, at 51 North 39th Street, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-8000.

Dr. Al-Ogaili's primary practice is Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Al-Ogaili is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Heart and Vascular Center Cherry Hill. Dmand AI also links Dr. Al-Ogaili to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Ogaili practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Al-Ogaili's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Al-Ogaili is licensed in Pennsylvania.

CMS data shows 336 Medicare services from Dr. Al-Ogaili across 7 procedure codes in 2024, for 204 Medicare patients. Medicare paid $21,092 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 204 Medicare patients who saw Dr. Al-Ogaili in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Ogaili's median patient age at 62, with 43% women.

In 2024, Dr. Al-Ogaili wrote 98 Medicare Part D claims for 32 patients. 97% of them were for generic drugs. CMS names the drug for 59 of them, across 2 drugs with 11 or more claims each, at $735 in total drug cost. In 2023, CMS named 56 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Al-Ogaili for performance year 2024, reported through an alternative payment model (APM). Dr. Al-Ogaili accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 74 procedures of coronary angioplasty and stenting by Dr. Al-Ogaili, more than 92% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 43 general payments to Dr. Al-Ogaili from 16 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 91% of the total. Boston Scientific Corporation paid the most, $791.